Related Experiment Video
Updated: Sep 25, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Hypertension and dialysis
Matthias P Hörl1, Walter H Hörl
1Diabetes Research Institute, University of Düsseldorf, Germany.
Insights
High blood pressure is common in dialysis patients, increasing cardiovascular disease risk. Managing hypertension involves lifestyle changes, dialysis adjustments, and medications, with optimal targets similar to the general population.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Dialysis patients exhibit high mortality rates, significantly linked to chronic hypertension and cardiovascular disease (CVD) risk factors.
- Hypertension in this population exacerbates risks for left ventricular hypertrophy, coronary artery disease, congestive heart failure, and cerebrovascular events.
Purpose of the Study:
- To review the challenges and therapeutic strategies for managing hypertension in patients undergoing dialysis.
- To outline current recommendations for blood pressure control in the dialysis population.
Main Methods:
- Review of therapeutic options for blood pressure normalization in dialysis patients.
- Discussion of dietary modifications, dialysate composition adjustments, and various hemodialysis schedules (long, short daily, nocturnal).
- Consideration of factors affecting blood pressure in peritoneal dialysis, including residual renal function and hyperhydration.
Main Results:
- Dietary salt/fluid restriction and reduced dialysate sodium are key interventions.
- Alternative hemodialysis schedules may offer benefits for blood pressure control.
- Avoiding hyperhydration is crucial for peritoneal dialysis patients; antihypertensive medications like ACE inhibitors, beta-blockers, and calcium channel blockers are recommended when necessary.
Conclusions:
- Optimal blood pressure targets for dialysis patients are consistent with general population guidelines.
- A multi-faceted approach combining lifestyle, dialysis modality adjustments, and pharmacotherapy is essential for effective hypertension management in dialysis patients.
Abstract:
The high mortality rate seen in dialysis patients is related to long-standing high blood pressure and the presence of other traditional as well as non-traditional risk factors for cardiovascular disease. Hypertension is associated with increased risk for left ventricular hypertrophy, coronary artery disease, congestive heart failure and cerebrovascular complications. High blood pressure is frequent and difficult to control in the dialysis population. Available therapeutic options to normalize blood pressure in these patients include dietary salt and fluid restriction in combination with reduction of dialysate sodium concentration. A possible treatment option for these patients may be long, slow hemodialysis (3 x 8 h per week); short daily hemodialysis (2-3 h 7 times per week); nocturnal hemodialysis (6-7 times overnight per week). Reduction of residual renal function is a major cause of blood pressure increase in the peritoneal dialysis patient population. Therefore, hyperhydration should be avoided. If antihypertensive medication is needed, ACE inhibitors, beta-blockers and/or calcium channel blockers are recommended. Optimal blood pressure in dialysis patients is not different from recommendations for the general population.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Hemodialysis III: Nursing Management
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Action of Diuretics
Hemodialysis I: Introduction